Endocannabinoid System in Autism Development Research
Maternal cannabis exposure autism risk is linked to behavioral problems and developmental delays in children. Research shows stronger associations in children with autism spectrum disorder symptoms. Understanding these risks is crucial for clinical…
Clinical Insights on Cannabis Induced Psychosis and Psychotic Disorders
Cannabis induced psychosis schizophrenia bipolar risk is a critical clinical concern requiring careful long-term psychiatric monitoring. Patients with cannabis induced psychosis often develop schizophrenia spectrum or bipolar disorders. Early specialist…
Research on Maternal Cannabis Exposure and Offspring Neurodevelopment
Maternal cannabis exposure risk ASD ADHD offspring is linked to modest increases in autism spectrum disorder and ADHD risks. Research highlights potential effects on fetal brain development via cannabinoid receptors. These findings emphasize the…
Endocannabinoid System Research: First-Episode Psychosis
First-episode psychosis predictors include substance use and aggressive behavior, which are linked to criminal legal involvement. Understanding these predictors helps clinicians implement early interventions. The endocannabinoid system research supports…
Understanding PTSD Alcohol and Cannabis Use in Trauma Survivors
PTSD alcohol cannabis use is a significant concern in trauma survivors, with insomnia symptoms predicting increased substance use. This highlights the endocannabinoid system's role in post-trauma recovery. Early treatment of insomnia may help reduce PTSD…
Clinical Evidence on PTSD Trauma-Focused Treatment and Cannabis
Clinical evidence shows that PTSD trauma-focused treatment cannabis use does not significantly reduce the efficacy of evidence-based PTSD protocols. Trauma-focused treatments remain effective for patients with co-occurring cannabis and substance use…
Endocannabinoid System Clinical Research in Back Pain
Clinical research on full-spectrum cannabis extract back pain treatment shows meaningful pain reduction in chronic low back pain patients. The VER-01 extract demonstrated safety and tolerability over 12 weeks. These findings support further investigation…
Endocannabinoid System Clinical Research: Pain Management Trial
The full-spectrum cannabis extract pain trial demonstrated significant pain reduction in adults with chronic low back pain. VER-01 was well-tolerated with manageable adverse effects. These findings support full-spectrum cannabis extract pain as a…
Prenatal Cannabis Exposure and Autism Development Insights
Prenatal cannabis exposure autism is linked to increased behavioral and developmental concerns in children. Maternal cannabis use during pregnancy shows stronger associations in children with autism spectrum disorder symptoms. These findings highlight…
Endocannabinoid System and Psychosis Risk: Clinical Evidence
Cannabis induced psychosis significantly increases the risk of developing schizophrenia spectrum and bipolar disorder. Clinical evidence highlights the need for careful diagnostic evaluation and monitoring. Early identification of cannabis induced…